Filter By Industry
Filter By Tag

Newsroom

Euphrates Vascular Press releases

1 - 2 of 2 Press Releases

Euphrates Vascular announces FDA clearance of the ICHOR Reperfusion System
Jan 17, 2019
Euphrates Vascular has received 510(k) clearance for sale of its ICHOR Percutaneous Reperfusion System, which is a minimally-invasive platform designed to treat organized thrombus and embolic events in the peripheral vasculature.

Pulse Therapeutics and ICHOR Vascular Merge to Form Euphrates Vascular
Jan 14, 2019
Biotechnology companies Pulse Therapeutics and ICHOR Vascular merge, bringing together technological synergies and experienced team members, to focus on treatment of vascular occlusions initial focus in limb ischemia and neurovascular applications.


Euphrates Vascular RSS Feed